These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 7755507)
1. Soluble IL-4 receptor, potential for therapeutic and prophylactic intervention. Gessner A; Röllinghoff M Behring Inst Mitt; 1994 Dec; (95):35-41. PubMed ID: 7755507 [TBL] [Abstract][Full Text] [Related]
2. Regulator and effector functions of T-cell subsets in human Leishmania infections. Kemp M APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493 [TBL] [Abstract][Full Text] [Related]
3. The production of soluble interleukin 4 receptors is preferentially regulated by the murine Th2 cell subset. Fernandez-Botran R; Chilton PM; Ma Y; Windsor JL; Street NE Cytokine; 1997 Mar; 9(3):166-77. PubMed ID: 9126705 [TBL] [Abstract][Full Text] [Related]
4. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice. Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695 [TBL] [Abstract][Full Text] [Related]
5. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor. Blum H; Wolf M; Enssle K; Röllinghoff M; Gessner A J Immunol; 1996 Sep; 157(5):1846-53. PubMed ID: 8757301 [TBL] [Abstract][Full Text] [Related]
6. Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4. Chilton PM; Fernandez-Botran R J Immunol; 1993 Dec; 151(11):5907-17. PubMed ID: 8245438 [TBL] [Abstract][Full Text] [Related]
7. Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4. Kropf P; Etges R; Schopf L; Chung C; Sypek J; Müller I J Immunol; 1997 Oct; 159(7):3434-43. PubMed ID: 9317142 [TBL] [Abstract][Full Text] [Related]
8. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations. Mocci S; Coffman RL J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090 [TBL] [Abstract][Full Text] [Related]
9. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. Fanslow WC; Clifford KN; Park LS; Rubin AS; Voice RF; Beckmann MP; Widmer MB J Immunol; 1991 Jul; 147(2):535-40. PubMed ID: 1830065 [TBL] [Abstract][Full Text] [Related]
10. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population. von der Weid T; Beebe AM; Roopenian DC; Coffman RL J Immunol; 1996 Nov; 157(10):4421-7. PubMed ID: 8906817 [TBL] [Abstract][Full Text] [Related]
11. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. Webb JR; Kaufmann D; Campos-Neto A; Reed SG J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412 [TBL] [Abstract][Full Text] [Related]
13. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states. Bretscher PA; Ogunremi O; Menon JN Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736 [TBL] [Abstract][Full Text] [Related]
14. Early IL-4 production does not predict susceptibility to Leishmania major. Scott P; Eaton A; Gause WC; di Zhou X; Hondowicz B Exp Parasitol; 1996 Nov; 84(2):178-87. PubMed ID: 8932767 [TBL] [Abstract][Full Text] [Related]
15. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. Romani L; Mencacci A; Tonnetti L; Spaccapelo R; Cenci E; Puccetti P; Wolf SF; Bistoni F J Immunol; 1994 Dec; 153(11):5167-75. PubMed ID: 7963574 [TBL] [Abstract][Full Text] [Related]
16. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4. Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868 [TBL] [Abstract][Full Text] [Related]
17. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12. Himmelrich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA; Launois P J Immunol; 1998 Dec; 161(11):6156-63. PubMed ID: 9834101 [TBL] [Abstract][Full Text] [Related]
18. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice. Mayrand SM; Healy PA; Torbett BE; Green WR Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS). Akarid K; Pocidalo MA; Desforges B; Sinet M Eur Cytokine Netw; 1995; 6(3):181-5. PubMed ID: 8589275 [TBL] [Abstract][Full Text] [Related]
20. Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis. Gessner A; Schröppel K; Will A; Enssle KH; Lauffer L; Röllinghoff M Infect Immun; 1994 Oct; 62(10):4112-7. PubMed ID: 7927664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]